<?xml version='1.0' encoding='utf-8'?>
<document id="18685566"><sentence text="Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding."><entity charOffset="32-44" id="DDI-PubMed.18685566.s1.e0" text="sulfonamides" /><entity charOffset="49-54" id="DDI-PubMed.18685566.s1.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.18685566.s1.e0" e2="DDI-PubMed.18685566.s1.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s1.e0" e2="DDI-PubMed.18685566.s1.e1" /></sentence><sentence text="The aim of this study was to determine whether a potential pharmacokinetic interaction between warfarin and orally administered anti-infectives increases the risk of hospitalization for gastrointestinal (GI) bleeding in warfarin users" /><sentence text=" We conducted a nested case-control and case-crossover study using US Medicaid data" /><sentence text=" Logistic regression was used to determine the association between GI bleeding and prior use of ciprofloxacin, levofloxacin, gatifloxacin, co-trimoxazole, or fluconazole vs"><entity charOffset="96-109" id="DDI-PubMed.18685566.s4.e0" text="ciprofloxacin" /><entity charOffset="111-123" id="DDI-PubMed.18685566.s4.e1" text="levofloxacin" /><entity charOffset="125-137" id="DDI-PubMed.18685566.s4.e2" text="gatifloxacin" /><entity charOffset="139-153" id="DDI-PubMed.18685566.s4.e3" text="co-trimoxazole" /><entity charOffset="158-169" id="DDI-PubMed.18685566.s4.e4" text="fluconazole" /><entity charOffset="148-158" id="DDI-PubMed.18685566.s4.e5" text="azole" /><entity charOffset="164-174" id="DDI-PubMed.18685566.s4.e6" text="azole" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e1" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e5" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e0" e2="DDI-PubMed.18685566.s4.e6" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e1" e2="DDI-PubMed.18685566.s4.e1" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e1" e2="DDI-PubMed.18685566.s4.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e1" e2="DDI-PubMed.18685566.s4.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e1" e2="DDI-PubMed.18685566.s4.e5" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e1" e2="DDI-PubMed.18685566.s4.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e1" e2="DDI-PubMed.18685566.s4.e6" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e2" e2="DDI-PubMed.18685566.s4.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e2" e2="DDI-PubMed.18685566.s4.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e2" e2="DDI-PubMed.18685566.s4.e5" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e2" e2="DDI-PubMed.18685566.s4.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e2" e2="DDI-PubMed.18685566.s4.e6" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e3" e2="DDI-PubMed.18685566.s4.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e3" e2="DDI-PubMed.18685566.s4.e5" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e3" e2="DDI-PubMed.18685566.s4.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e3" e2="DDI-PubMed.18685566.s4.e6" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e5" e2="DDI-PubMed.18685566.s4.e5" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e5" e2="DDI-PubMed.18685566.s4.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e5" e2="DDI-PubMed.18685566.s4.e6" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e4" e2="DDI-PubMed.18685566.s4.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s4.e4" e2="DDI-PubMed.18685566.s4.e6" /></sentence><sentence text=" no exposure and also vs" /><sentence text=" use of cephalexin, which would not be expected to interact with warfarin"><entity charOffset="8-18" id="DDI-PubMed.18685566.s6.e0" text="cephalexin" /><entity charOffset="65-73" id="DDI-PubMed.18685566.s6.e1" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.18685566.s6.e0" e2="DDI-PubMed.18685566.s6.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s6.e0" e2="DDI-PubMed.18685566.s6.e1" /></sentence><sentence text=" All of the anti-infectives examined were associated with elevated odds ratios (ORs) when compared to no exposure to these drugs" /><sentence text=" With cephalexin data as the reference, the ORs for co-trimoxazole (OR: 1"><entity charOffset="6-16" id="DDI-PubMed.18685566.s8.e0" text="cephalexin" /><entity charOffset="44-47" id="DDI-PubMed.18685566.s8.e1" text="ORs" /><entity charOffset="52-66" id="DDI-PubMed.18685566.s8.e2" text="co-trimoxazole" /><entity charOffset="68-70" id="DDI-PubMed.18685566.s8.e3" text="OR" /><entity charOffset="61-62" id="DDI-PubMed.18685566.s8.e4" text="azole" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e0" e2="DDI-PubMed.18685566.s8.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e0" e2="DDI-PubMed.18685566.s8.e1" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e0" e2="DDI-PubMed.18685566.s8.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e0" e2="DDI-PubMed.18685566.s8.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e0" e2="DDI-PubMed.18685566.s8.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e1" e2="DDI-PubMed.18685566.s8.e1" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e1" e2="DDI-PubMed.18685566.s8.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e1" e2="DDI-PubMed.18685566.s8.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e1" e2="DDI-PubMed.18685566.s8.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e2" e2="DDI-PubMed.18685566.s8.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e2" e2="DDI-PubMed.18685566.s8.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e2" e2="DDI-PubMed.18685566.s8.e3" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e4" e2="DDI-PubMed.18685566.s8.e4" /><pair ddi="false" e1="DDI-PubMed.18685566.s8.e4" e2="DDI-PubMed.18685566.s8.e3" /></sentence><sentence text="68 (95% confidence interval (CI): 1" /><sentence text="21-2" /><sentence text="33) in the prior 6-10 days) and fluconazole (OR: 2"><entity charOffset="32-43" id="DDI-PubMed.18685566.s11.e0" text="fluconazole" /><entity charOffset="45-47" id="DDI-PubMed.18685566.s11.e1" text="OR" /><entity charOffset="38-39" id="DDI-PubMed.18685566.s11.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.18685566.s11.e0" e2="DDI-PubMed.18685566.s11.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s11.e0" e2="DDI-PubMed.18685566.s11.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s11.e0" e2="DDI-PubMed.18685566.s11.e1" /><pair ddi="false" e1="DDI-PubMed.18685566.s11.e2" e2="DDI-PubMed.18685566.s11.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s11.e2" e2="DDI-PubMed.18685566.s11.e1" /></sentence><sentence text="09 (95% CI: 1" /><sentence text="34-3" /><sentence text="26) in the prior 11-15 days) were significantly elevated" /><sentence text=" Warfarin users who had received an anti-infective agent showed a substantially increased risk of GI bleeding" /><sentence text=" However, a drug-drug interaction with warfarin was evident only for co-trimoxazole and fluconazole"><entity charOffset="88-99" id="DDI-PubMed.18685566.s16.e0" text="fluconazole" /><entity charOffset="78-88" id="DDI-PubMed.18685566.s16.e1" text="azole" /><entity charOffset="94-104" id="DDI-PubMed.18685566.s16.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.18685566.s16.e1" e2="DDI-PubMed.18685566.s16.e1" /><pair ddi="false" e1="DDI-PubMed.18685566.s16.e1" e2="DDI-PubMed.18685566.s16.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s16.e1" e2="DDI-PubMed.18685566.s16.e2" /><pair ddi="false" e1="DDI-PubMed.18685566.s16.e0" e2="DDI-PubMed.18685566.s16.e0" /><pair ddi="false" e1="DDI-PubMed.18685566.s16.e0" e2="DDI-PubMed.18685566.s16.e2" /></sentence><sentence text="" /></document>